在免疫疗法时代的多层甲状腺瘤
Mathieu Chevallier1, Floryane Kim1, Alex Friedlaender1,2
1Department of Oncology, University Hospital Geneva, Geneva, Switzerland.
Clinical Medicine Insights. Oncology
|July 26, 2023
概括
免疫疗法,包括伊皮利马布和尼沃马布,现在是治疗晚期肺间皮瘤的标准一线治疗方法. 然而,大多数患者缺乏长期益处,强调需要更好的生物标志物和治疗序列策略.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 恶性多层层层髓瘤 恶性多层层层层瘤
背景情况:
- 在过去的十年中,免疫疗法改变了癌症治疗.
- 排骨间皮瘤是一种罕见而具有攻击性的癌症,现在正受益于免疫治疗的进步.
- 伊皮利穆马布和尼沃卢穆马布的组合已成为治疗晚期肺间皮瘤的新标准,改善了整体存活率.
研究的目的:
- 讨论目前对肺部间皮瘤的管理.
- 为了确定一个最佳的治疗序列为肺部间皮瘤患者.
- 为了突出这一罕见疾病正在进行的有前途的临床试验.
主要方法:
- 审查目前的免疫治疗方法在多间皮质瘤.
- 根据患者表现状况和瘤组织学分析治疗序列的分析.
- 讨论新兴的治疗策略和正在进行的试验.
主要成果:
- 免疫疗法 (ipilimumab和nivolumab) 在一线先进的多叶膜间皮瘤中比化疗改善了存活率.
- 大多数患者无法从当前治疗中获得长期益处.
- 对于多间皮质瘤,预测和预后生物标志物显著缺乏.
结论:
- 虽然免疫疗法是新的标准,但在实现长期患者益处方面仍然存在挑战.
- 在第一线进展后,治疗的最佳顺序至关重要,但缺乏可靠的数据.
- 进一步的研究和正在进行的试验至关重要,以改善胸膜间皮瘤患者的治疗结果.
相关概念视频
Pleural Disorders: Types and Brief Description
239
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
239
Tumor Immunotherapy
558
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
558
Pleural Effusion II: Symptoms and Management
212
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
212
Pleura of the Lungs
2.2K
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
2.2K
Cancer Vaccines
405
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
405
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


